Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- AB 824 (1)
- Addiction (1)
- Anti-competition law (1)
- California AB 824 (1)
- Civil litigation (1)
-
- Community caretaking (1)
- Community caretaking exception (1)
- Competitive drug prices (1)
- Constitutional law (1)
- Drug costs (1)
- Drug prices (1)
- Fourth amendment (1)
- Law enforcement (1)
- Lower drug prices (1)
- Lower medical costs (1)
- Medical costs (1)
- Opioid distributors (1)
- Opioid epidemic (1)
- Opioid manufacturers (1)
- Opioid pharmacies (1)
- Opioids (1)
- Police (1)
- Public health (1)
- Public health crisis (1)
- Reverse payment settlements (1)
- Warrant requirement (1)
- Welfare check (1)
- Wellness check (1)
Articles 1 - 3 of 3
Full-Text Articles in Law
Litigating An Epidemic: California Plaintiffs In The National Opioid Litigation, Samantha T. Pannier
Litigating An Epidemic: California Plaintiffs In The National Opioid Litigation, Samantha T. Pannier
Loyola of Los Angeles Law Review
Can litigation solve a public health epidemic? The opioid epidemic has cost California 24,885 lives, $4.3 billion, and counting. As a result, over 500 California cities, counties, and sovereign Indian tribes are engaged in civil litigation against over twenty different opioid manufacturers, distributors, and pharmacies for their role in creating and profiting from an epidemic of addiction. Cases brought by California plaintiffs account for about 20 percent of all ongoing opioid litigation nationally. This Note situates the claims of three California plaintiffs— the State, the County of Mariposa, and the City of Los Angeles—within the context of the ongoing national …
Shifting The Burden On Pay-For-Delay Challenges: Analyzing Ab 824’S Effects On Reverse Payment Settlements And Drug Costs, Kevin Wallentine
Shifting The Burden On Pay-For-Delay Challenges: Analyzing Ab 824’S Effects On Reverse Payment Settlements And Drug Costs, Kevin Wallentine
Loyola of Los Angeles Law Review
Antitrust scholars and agencies have recognized the anticompetitive impact of reverse payment settlements—in which branded and generic drug companies settle patent disputes, typically by delaying the entry of generics into the market. Despite clear competition concerns, these settlements are typically subject to a rule of reason analysis that puts the burden on enforcers and plaintiffs to prove their anticompetitive harms. Recent California legislation—AB 824—shifts the burden to the settling drug companies to prove their arrangement is not anticompetitive. AB 824 presents an opportunity for advocates of lower drug costs but still faces hurdles and shortfalls. This Note examines the efficacy …
Law Enforcement Welfare Checks And The Community Caretaking Exception To The Fourth Amendment Warrant Requirement, Andrea L. Steffan
Law Enforcement Welfare Checks And The Community Caretaking Exception To The Fourth Amendment Warrant Requirement, Andrea L. Steffan
Loyola of Los Angeles Law Review
No abstract provided.